chlorine has been researched along with carbostyril in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (11.27) | 18.2507 |
2000's | 7 (9.86) | 29.6817 |
2010's | 42 (59.15) | 24.3611 |
2020's | 14 (19.72) | 2.80 |
Authors | Studies |
---|---|
Akahane, K; Fukuda, H; Ito, Y; Kimura, Y; Miyasaka, T | 1 |
Meyer, MT; Weinberg, HS; Ye, Z | 1 |
Grepl, M; Hradil, P; Lemr, K; Roithová, J | 1 |
Baty, JW; Berridge, MV; Dangerfield, EM; Grasso, CH; Harper, JL; Martin, WJ; Mulchin, BJ; Newton, CG; Plunkett, CH; Stocker, BL; Timmer, MS; Walton, MC | 1 |
Du, Y; Li, M; Wei, D | 1 |
Ebihara, A; Fujimura, A; Harada, K; Ohashi, K; Sasaki, M; Shiga, T; Sudoh, T; Tateishi, T | 1 |
Imai, M; Nakakuki, M; Nishijima, K; Notsu, T; Shinkawa, T; Yamasaki, F; Yoshitomi, K | 1 |
Fukuda, K; Iwakura, K; Nishimura, N; Shindo, Y; Sumi, N; Tamura, K; Yamazaki, S | 1 |
Ishibashi, S; Iwakura, K; Nakazawa, M; Shindo, Y; Sumi, N; Tawaratani, T; Uchimoto, H; Yoshida, M | 1 |
Brand, IA; Kleineke, JW | 1 |
Bode, H; Fromm, M; Riecken, EO; Schmitz, H; Scholz, P; Schulzke, JD | 1 |
Kato, H; Murata, M; Nagata, O; Sai, Y; Tamai, I; Tsuji, A | 1 |
Erol, K; Safak, C; Simşek, R; Sirmagül, B | 1 |
Minamikawa, Ji; Nishi, T; Torisawa, Y | 1 |
Huang, L; Kirschke, CP; Yu, YY; Zhang, Y | 1 |
Kawago, K; Matsuda, K; Nishio, T; Sano, Y; Uchiyama, M; Yamada, T | 1 |
Arumugam, V; Ashlock, M; Burton, B; Cao, D; Decker, C; Frizzell, RA; Grootenhuis, PD; Hadida, S; Hazlewood, A; Joubran, J; McCartney, J; Negulescu, P; Neuberger, T; Olson, ER; Singh, A; Turnbull, A; Van Goor, F; Wine, JJ; Yang, J; Young, C; Zhou, J | 1 |
Accurso, FJ; Aitken, ML; Ashlock, MA; Boyle, MP; Campbell, PW; Clancy, JP; Donaldson, SH; Dong, Q; Dunitz, JM; Durie, PR; Freedman, SD; Hornick, DB; Konstan, MW; Mayer-Hamblett, N; Moss, RB; Olson, ER; Ordoñez, CL; Pilewski, JM; Ramsey, BW; Rose, LM; Rowe, SM; Rubenstein, RC; Sagel, SD; Stone, AJ; Uluer, AZ; Zha, J | 1 |
Kantevari, S; Patpi, SR; Sridhar, B; Sriram, D; Yogeeswari, P | 1 |
Borowitz, DS; Flume, PA; Geller, DE; Li, H; Liou, TG; Ordoñez, CL; Yen, K | 1 |
Chowdhury, BA; Durmowicz, AG; Rosebraugh, CJ; Witzmann, KA | 2 |
Sermet-Gaudelus, I | 1 |
Elborn, JS | 1 |
Mueller, P; Rodman, D; Schmelz, A; Seliger, VI; Van Goor, F | 1 |
Burton, B; Hoffman, BJ; Van Goor, F; Yu, H | 1 |
Heltshe, SL; Mayer-Hamblett, N; Rowe, SM | 2 |
Accurso, FJ; Beamer, JR; Clancy, JP; Cohen, M; Dong, Q; Hathorne, H; Hill, A; Liu, B; Olson, ER; Ordoñez, CL; Rowe, SM; Stone, AJ | 1 |
Harrison, MJ; Murphy, DM; Plant, BJ | 1 |
McGarry, ME; Nielson, DW | 1 |
Blanchard, E; Conti, M; Finkbeiner, WE; Gruenert, DC; Lao, A; Mika, D; Namkung, W; Richter, W; Scheitrum, C; Verkman, AS; Xie, M; Zlock, L | 1 |
Baasov, T; Bedwell, DM; Belakhov, V; Biswas, S; Chen, F; Dai, Y; Du, M; Hong, J; J Bridges, R; Jackson, LA; Mutyam, V; Rowe, SM; Schacht, J; Shalev, M; Tang, L; Xue, X | 1 |
Barry, PJ; Horsley, AR; Jones, AM; Webb, AK | 1 |
Grasemann, H; Ratjen, F; Solomon, M | 1 |
Accurso, FJ; Ashlock, MA; Campbell, PW; Clancy, JP; Dong, Q; Heltshe, SL; Hoch, HE; Konstan, MW; Ordonez, CL; Ramsey, BW; Rowe, SM; Stone, AJ; Van Goor, F; Zha, J | 1 |
Bergin, DA; Clynes, M; Hayes, E; Henry, M; Jundi, B; Keenan, J; McCarthy, C; McElvaney, NG; McElvaney, OJ; Meleady, P; Molloy, K; Pohl, K; Reeves, EP; White, MM | 1 |
Bell, SC; Boyle, MP; Huang, X; Konstan, MW; McColley, SA; Patel, NR; Rietschel, E; Rodman, D; Rowe, SM; Waltz, D | 1 |
Apaja, PM; Avramescu, RG; Bagdany, M; Borot, F; Finkbeiner, WE; Hegedus, T; Lukacs, GL; Perdomo, D; Phuan, PW; Szollosi, D; Veit, G; Verkman, AS; Wu, YS | 1 |
Back, DF; Goulart, TA; Mantovani, AC; Menezes, PH; Zeni, G | 1 |
Ahrens, R; Elborn, JS; Johnson, C; Konstan, MW; Munck, A; Plant, BJ; Rodriguez, S | 1 |
Cooke, J; Cunningham, S; Davies, JC; Green, Y; Harris, WT; Lapey, A; Regelmann, WE; Robertson, S; Rosenfeld, M; Sawicki, GS; Southern, KW | 1 |
Bilton, D; Davies, JC; De Boeck, K; Le Camus, C; Milenković, D; Vermeulen, F | 1 |
Beekman, JM; Berkers, G; Bronsveld, I; Clevers, H; de Jonge, HR; de Rijke, YB; de Winter-de Groot, KM; Dekkers, JF; Escher, JC; Heijerman, HG; Houwen, RH; Janssens, HM; Kruisselbrink, E; Majoor, CJ; Nieuwenhuis, EE; van de Graaf, EA; van der Ent, CK; Vleggaar, FP; Vonk, A | 1 |
Bassinet, L; Cohen, M; Escabasse, V; Friedman, H; Hatton, A; Le Bourgeois, M; Livnat, G; Lucidi, V; Mesbahi, M; Nguyen-Khoa, T; Sermet-Gaudelus, I; Shteinberg, M; Wilschanski, M | 1 |
Beusmans, J; Fidler, MC; Panorchan, P; Van Goor, F | 1 |
Cao, X; Cheng, CH; Gao, D; Huang, J; Lan, C; Sun, Q; Yang, D; Zhang, G; Zhou, WL; Zuo, W | 1 |
Finkbeiner, WE; Illek, B; Ly, NP; McGarry, ME; Moreno, C; Nielson, DW; Olshansky, S; Zlock, L | 1 |
Casavola, V; Castellani, S; Conese, M; D'Oria, S; Favia, M; Gallo, C; Guerra, L; Leonetti, G; Manca, A; Mariggiò, MA; Montemurro, P; Polizzi, AM; Santostasi, T | 1 |
Arnold, C; Hentschel, J; Mainz, JG; Tabori, H | 1 |
Abou Alaiwa, MH; Carter, S; Grogan, B; Launspach, JL; McKone, EF; Singh, PK; Stoltz, DA; Welsh, MJ; Zabner, J | 1 |
Burr, L; Daines, C; Keating, D; Mall, MA; Marigowda, G; McKee, CM; McKone, EF; Moskowitz, SM; Ramsey, BW; Robertson, S; Rowe, SM; Sass, LA; Savage, J; Simard, C; Taylor-Cousar, JL; Tullis, E; Van Goor, F; Waltz, D; Xuan, F; Young, T | 1 |
Brown, C; Davies, JC; Horsley, A; Mall, MA; McKee, CM; McKone, EF; Moskowitz, SM; Plant, BJ; Prais, D; Ramsey, BW; Robertson, S; Rowe, SM; Shilling, RA; Simard, C; Taylor-Cousar, JL; Tullis, E; Uluer, A; Van Goor, F; Waltz, D; Xuan, F; Young, T | 1 |
Dunn, C; Farahmand, M; Horii, RI; Kim, J; Milla, CE; Moss, RB; Thomas, EAC; Wine, JJ | 1 |
Course, CW; Hanks, R | 1 |
Braggion, C; Carnovale, V; Castellani, C; Cimino, G; Colangelo, C; Ferrara, N; Francalanci, M; Iacotucci, P; Leonetti, G; Lucidi, V; Manca, A; Salvatore, D; Vitullo, P | 1 |
Dřevínek, P; Jain, R; Lands, LC; Mall, MA; Marigowda, G; McKee, CM; McKone, EF; Middleton, PG; Moskowitz, SM; Nair, N; Polineni, D; Ramsey, BW; Rowe, SM; Savage, J; Simard, C; Taylor-Cousar, JL; Tian, S; Tullis, E; Vermeulen, F; Waltz, D; Xuan, F | 1 |
Guimbellot, JS; Heltshe, SL; Jain, M; Jovanovic, B; Rowe, SM; Sagel, SD; Secunda, KE | 1 |
Aalbers, BL; Arets, HGM; Bronsveld, I; de Kiviet, AC; de Winter-de Groot, KM; Heijerman, HGM; Hofland, RW; Kruijswijk, MA; Michel, S; Schotman, S; van der Ent, CK; van Oirschot-van de Ven, MMM | 1 |
Bridges, RJ; Hastings, ML; Michaels, WE | 1 |
Beekman, JM; Graeber, SY; Hirtz, S; Kruisselbrink, E; Mall, MA; van der Ent, CK; van Mourik, P; Vonk, AM | 1 |
Clancy, JP; Konstan, MW; Mayer-Hamblett, N; Odem-Davis, K; Rowe, SM; Skalland, M; VanDevanter, DR; Zemanick, ET | 1 |
Chen, J; Conrath, K; Falk Libby, E; Li, Y; Mutyam, V; Peng, N; Rowe, SM; Sharma, J; Singh, AK; Tang, LP | 1 |
Amato, F; Castaldo, G; Castellani, C; Ferrari, B; Galietta, LJV; Taccetti, G; Terlizzi, V | 1 |
Dittrich, AM; Hansen, G; Junge, S; Nietert, M; Pallenberg, ST; Ringshausen, FC; Sauer-Heilborn, A; Tümmler, B | 1 |
Bijvelds, MJC; de Jonge, HR; Janssens, HM; Meijsen, KF; Roest, HP; Roos, FJM; van der Laan, LJW; Verstegen, MMA | 1 |
Astori, A; Gupta, GD; Iazzi, M; Raught, B; St-Germain, J | 1 |
Branstetter, BF; Goralski, JL; Kimple, AJ; Lee, SE; Nouraie, SM; Pilewski, JM; Senior, BA; Shaffer, AD; Stapleton, AL; Zemke, AC | 1 |
Aksit, MA; Bridges, RJ; Cutting, GR; Faino, AV; Gibson, RL; Goralski, JL; Ling, H; Merlo, CA; Montemayor, K; Onchiri, FM; Osorio, DL; Patel, SU; Paul, KC; Raraigh, KS; Sciortino, S; Sharma, N; Sheppard, DN; Thakerar, A; Wang, Y; West, NE; Worthington, EN | 1 |
Arques, A; Escudero-Oñate, C; Micó, P; Mora, M; Oller, I; Sciscenko, I | 1 |
Baroni, D; Ludovico, A; Moran, O | 1 |
2 review(s) available for chlorine and carbostyril
Article | Year |
---|---|
Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation.
Topics: Adolescent; Adult; Aminophenols; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Predisposition to Disease; Humans; Lung; Molecular Targeted Therapy; Mutation; Patient Selection; Phenotype; Precision Medicine; Quinolones; Respiratory System Agents; Sweat; Time Factors; Treatment Outcome; Young Adult | 2013 |
Newborn screening for cystic fibrosis: Is there benefit for everyone?
Topics: Aminophenols; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; False Positive Reactions; Health Policy; Humans; Infant, Newborn; Mutation; Neonatal Screening; Penetrance; Phenotype; Quinolones; Risk Assessment; Sweat | 2019 |
15 trial(s) available for chlorine and carbostyril
Article | Year |
---|---|
Renal clearance of lomefloxacin is decreased by furosemide.
Topics: Adult; Anti-Infective Agents; Chlorides; Double-Blind Method; Drug Interactions; Fluoroquinolones; Furosemide; Humans; Male; Potassium; Quinolones; Sodium; Urodynamics | 1994 |
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.
Topics: Adult; Aminophenols; Chlorides; Cross-Over Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Ion Channels; Male; Membrane Potentials; Middle Aged; Mutation; Nasal Mucosa; Quinolones; Sweat; Young Adult | 2010 |
Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation.
Topics: Adolescent; Adult; Alleles; Aminophenols; Biomarkers; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Female; Homozygote; Humans; Male; Middle Aged; Mutation; Pharmacogenetics; Quinolones; Sweat; Treatment Outcome; Young Adult | 2012 |
Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation.
Topics: Adult; Amino Acid Substitution; Aminophenols; Biological Transport; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Demography; Epithelial Sodium Channels; Female; Humans; Male; Membrane Potentials; Middle Aged; Mutation; Nose; Placebos; Quinolones; Sample Size; Sodium; Solutions; Young Adult | 2013 |
Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data.
Topics: Adult; Aminophenols; Biomarkers; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Mutation; Nasal Mucosa; Quinolones; Reproducibility of Results; Respiratory System Agents; Specimen Handling; Sweat; Treatment Outcome | 2014 |
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Base Sequence; Benzodioxoles; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Heterozygote; Homozygote; Humans; Male; Quinolones; Sequence Deletion; Sweat; Young Adult | 2014 |
Efficacy response in CF patients treated with ivacaftor: post-hoc analysis.
Topics: Adolescent; Adult; Aminophenols; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Female; Forced Expiratory Volume; Humans; Male; Mutation; Numbers Needed To Treat; Quinolones; Respiratory Function Tests; Surveys and Questionnaires; Sweat; Weight Gain; Young Adult | 2015 |
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study.
Topics: Aminophenols; Child, Preschool; Chloride Channel Agonists; Chlorides; Cough; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Forced Expiratory Volume; Genotype; Humans; Male; Mutation; Quinolones; Sweat | 2016 |
Variability of sweat chloride concentration in subjects with cystic fibrosis and G551D mutations.
Topics: Adolescent; Adult; Aminophenols; Biological Variation, Population; Biomarkers; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Male; Middle Aged; Mutation; Quinolones; Retrospective Studies; Sweat | 2017 |
In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.
Topics: Administration, Oral; Adolescent; Adult; Aminophenols; Chloride Channel Agonists; Chlorides; Cross-Over Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Male; Middle Aged; Quinolones; Sweat; Treatment Outcome; Young Adult | 2017 |
CFTR-dependent chloride efflux in cystic fibrosis mononuclear cells is increased by ivacaftor therapy.
Topics: Adolescent; Adult; Aminophenols; C-Reactive Protein; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Leukocytes, Mononuclear; Male; Mutation; Neutrophils; Quinolones; Respiratory Function Tests; Sweat; Young Adult | 2017 |
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Topics: Adolescent; Adult; Alleles; Aminophenols; Benzodioxoles; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Genotype; Humans; Indoles; Male; Mutation; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Sweat; Young Adult | 2018 |
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Topics: Adolescent; Adult; Alleles; Aminophenols; Benzodioxoles; Cells, Cultured; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Genotype; Humans; Indoles; Male; Mutation; Pyrazoles; Pyrrolidines; Quinolones; Sweat; Young Adult | 2018 |
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults.
Topics: Adult; Aminophenols; Chloride Channel Agonists; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Female; Humans; Male; Quinolones; Sweat; Sweat Glands; Sweating | 2018 |
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
Topics: Adolescent; Adult; Aminophenols; Benzodioxoles; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Genotype; Humans; Indoles; Male; Mutation; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Sweat; Young Adult | 2019 |
54 other study(ies) available for chlorine and carbostyril
Article | Year |
---|---|
Inhibition of GABAA receptor chloride channel by quinolones and norfloxacin-biphenylacetic acid hybrid compounds.
Topics: Animals; Anti-Infective Agents; Chloride Channels; Chlorine; Enoxacin; GABA Agonists; GABA Antagonists; GABA-A Receptor Antagonists; Male; Muscimol; Norfloxacin; Phenylacetates; Pyridazines; Quinolones; Rats; Rats, Wistar; Synaptosomes | 1996 |
Trace analysis of trimethoprim and sulfonamide, macrolide, quinolone, and tetracycline antibiotics in chlorinated drinking water using liquid chromatography electrospray tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Chlorine; Chromatography, Liquid; Macrolides; Quinolones; Spectrometry, Mass, Electrospray Ionization; Sulfonamides; Tetracyclines; Trimethoprim; Water Supply | 2007 |
Ionization and fragmentation of monochloro-isomers of 3-hydroxy-2-phenyl-4(1H)-quinolinone.
Topics: Chlorine; Isomerism; Quinolones; Spectrometry, Mass, Electrospray Ionization | 2008 |
The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones.
Topics: Amines; Anti-Inflammatory Agents; Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Chlorine; HL-60 Cells; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Quinolones; Quinones; Stereoisomerism; Sulfur | 2010 |
Genotoxicity of quinolone antibiotics in chlorination disinfection treatment: formation and QSAR simulation.
Topics: Anti-Bacterial Agents; Chlorine; Disinfectants; Disinfection; DNA Damage; Microbial Viability; Quantitative Structure-Activity Relationship; Quinolones; Salmonella typhimurium; Water Pollutants, Chemical; Water Purification | 2016 |
Loop and distal actions of a novel diuretic, M17055.
Topics: Animals; Chlorides; Diuresis; Diuretics; Dogs; Female; Furosemide; In Vitro Techniques; Infusions, Intravenous; Kidney Tubules; Loop of Henle; Male; Oximes; Potassium; Quinolones; Rabbits; Sodium | 1993 |
[A 4-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 4-week recovery test].
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cecum; Chlorides; Dioxolanes; Drinking; Eating; Female; Fluoroquinolones; gamma-Globulins; Kidney Tubular Necrosis, Acute; Male; Organ Size; Piperazines; Potassium; Quinolones; Rats; Rats, Sprague-Dawley; Weight Gain | 1996 |
[A 13-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 5-week recovery test].
Topics: Administration, Oral; Animals; Anti-Infective Agents; Blood Proteins; Blood Urea Nitrogen; Cartilage, Articular; Cecum; Chlorides; Dioxolanes; Female; Fluoroquinolones; Kidney Tubular Necrosis, Acute; Male; Organ Size; Piperazines; Potassium; Quinolones; Rats; Rats, Sprague-Dawley; Triglycerides | 1996 |
Rapid changes in intracellular Zn2+ in rat hepatocytes.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Arginine Vasopressin; Cadmium; Chlorides; Copper; Dose-Response Relationship, Drug; Fluorescent Dyes; Hemostatics; Lead; Liver; Mercury; Metallothionein; Nickel; Quinolones; Rats; Tosyl Compounds; Zinc; Zinc Compounds | 1997 |
IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon.
Topics: Chlorides; Colon; Cyclooxygenase Inhibitors; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Enteric Nervous System; Humans; In Vitro Techniques; Indomethacin; Interferon-alpha; Interferon-gamma; Interleukin-1; Interleukin-6; Interleukin-8; Intestinal Mucosa; Ion Transport; Lipoxygenase Inhibitors; Pyrans; Quinolones; Radioimmunoassay; Sodium; Tetrodotoxin; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Carrier-mediated lung distribution of HSR-903, a new quinolone antibacterial agent.
Topics: Algorithms; Animals; Anti-Infective Agents; Biological Transport; Carrier Proteins; Chlorides; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fluoroquinolones; In Vitro Techniques; Lung; Male; Perfusion; Quinolones; Rats; Rats, Sprague-Dawley; Sodium; Stereoisomerism | 1999 |
Studies on calcium antagonist activities of 2-ethyl-3-carbmethoxy-4-aryl- 5-oxo-6,6-dimethyl-1,4,5,6,7,8-hexahydroquinoline derivatives.
Topics: Animals; Barium Compounds; Calcium Channel Blockers; Carotid Arteries; Chlorides; Chromatography, Thin Layer; Female; Ileum; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Muscle, Smooth, Vascular; Nicardipine; Quinolones; Rats; Sheep; Spectrophotometry, Infrared; Structure-Activity Relationship | 2001 |
A study on the conversion of indanones into carbostyrils.
Topics: Alkanesulfonates; Catalysis; Chlorides; Hydroxyquinolines; Indans; Isomerism; Mesylates; Metals; Organometallic Compounds; Oximes; Quinolones; Solvents; Zirconium | 2003 |
The ZIP7 gene (Slc39a7) encodes a zinc transporter involved in zinc homeostasis of the Golgi apparatus.
Topics: Animals; beta-Galactosidase; Blotting, Northern; Blotting, Western; Brain; Cation Transport Proteins; Cell Line; Cell Line, Tumor; Chlorides; CHO Cells; Cricetinae; Cytoplasm; DNA, Complementary; Expressed Sequence Tags; Golgi Apparatus; Humans; K562 Cells; Liver; Membrane Proteins; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Mutation; Plasmids; Quinolones; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tissue Distribution; Tosyl Compounds; Zinc; Zinc Compounds | 2005 |
Effects of arginine vasotocin and vasopressin receptor antagonists on Na+ and Cl- transport in the isolated skin of two frog species, Hyla japonica and Rana nigromaculata.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Anura; Benzazepines; Biological Transport; Chlorides; Colforsin; Dose-Response Relationship, Drug; Electrophysiology; Female; In Vitro Techniques; Male; Piperidines; Quinolones; Receptors, Vasopressin; Skin; Sodium; Species Specificity; Time Factors; Vasotocin | 2008 |
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770.
Topics: Absorption; Amino Acid Substitution; Aminophenols; Animals; Bronchi; Cells, Cultured; Chlorides; Cilia; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Synergism; Epithelial Cells; Epithelial Sodium Channels; Humans; Ion Channel Gating; Mice; Mutation; NIH 3T3 Cells; Quinolines; Quinolones; Sodium | 2009 |
Synthesis and antitubercular evaluation of novel substituted aryl and thiophenyl tethered dihydro-6H-quinolin-5-ones.
Topics: Antitubercular Agents; Catalysis; Cesium; Chlorides; Crystallography, X-Ray; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Quinolones; Structure-Activity Relationship | 2011 |
Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience.
Topics: Aminophenols; Chlorides; Clinical Trials as Topic; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Forced Expiratory Volume; Humans; Outcome Assessment, Health Care; Quinolones; Sweat; Treatment Outcome | 2013 |
The impact of personalised therapies on respiratory medicine.
Topics: Aminophenols; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Predisposition to Disease; Humans; Lung; Molecular Targeted Therapy; Mutation; Patient Selection; Phenotype; Precision Medicine; Pulmonary Medicine; Quinolones; Respiratory System Agents; Sweat; Treatment Outcome | 2013 |
The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation.
Topics: Administration, Oral; Adolescent; Aminophenols; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Forced Expiratory Volume; Humans; Male; Mutation; Quinolones; Sensitivity and Specificity; Sweat; Weight Gain | 2013 |
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function.
Topics: Aminophenols; Animals; Cell Line; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; In Vitro Techniques; Ion Channel Gating; Mutation, Missense; Quinolones; Rats; Rats, Inbred F344; Thyroid Gland | 2014 |
Evaluating the predictive ability of sweat chloride.
Topics: Aminophenols; Chlorides; Cystic Fibrosis; Female; Humans; Male; Quinolones; Sweat | 2014 |
Ivacaftor in a G551D homozygote with cystic fibrosis.
Topics: Adolescent; Aminophenols; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Forced Expiratory Volume; Homozygote; Humans; Mutation; Quinolones; Sweat | 2013 |
Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N.
Topics: Aminophenols; Child; Chlorides; Cystic Fibrosis; Female; Humans; Mutation; Quinolones; Sweat | 2013 |
Response.
Topics: Aminophenols; Chlorides; Cystic Fibrosis; Humans; Outcome Assessment, Health Care; Quinolones; Sweat | 2013 |
Understanding the relationship between sweat chloride and lung function in cystic fibrosis.
Topics: Aminophenols; Chlorides; Cystic Fibrosis; Humans; Outcome Assessment, Health Care; Quinolones; Sweat | 2013 |
Anchored PDE4 regulates chloride conductance in wild-type and ΔF508-CFTR human airway epithelia.
Topics: Amiloride; Cells, Cultured; Chlorides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelium; Humans; Immunoprecipitation; Quinolones; Respiratory Mucosa; Rolipram | 2014 |
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor.
Topics: Aminoglycosides; Aminophenols; Animals; Biological Transport; Cell Line; Chlorides; Codon, Nonsense; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Drug Synergism; Genes, Reporter; Humans; Luciferases; Mice; Mice, Inbred CFTR; Mice, Transgenic; Organ of Corti; Quinolones; Rats; Rats, Inbred F344; Time Factors; Transfection | 2014 |
Sweat chloride is not a useful marker of clinical response to Ivacaftor.
Topics: Aminophenols; Biomarkers; Body Height; Body Weight; Chlorides; Cohort Studies; Cystic Fibrosis; Forced Expiratory Flow Rates; Humans; Lung; Prospective Studies; Quinolones; Spirometry; Sweat | 2014 |
Aquagenic wrinkling of the palms in a patient with cystic fibrosis.
Topics: Aminophenols; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genotype; Hand; Humans; Male; Quinolones; Skin Aging; Sweat; Water | 2013 |
A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.
Topics: Adult; Aminophenols; Cell Degranulation; Cells, Cultured; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrophoresis, Gel, Two-Dimensional; Female; Homeostasis; Humans; Immunoblotting; Magnesium; Male; Mutation; Neutrophils; Protein Transport; Proteome; Proteomics; Quinolones; rab GTP-Binding Proteins; rab27 GTP-Binding Proteins; Sodium; Tumor Necrosis Factor-alpha; Young Adult | 2014 |
Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.
Topics: Aminophenols; Bronchi; Cell Membrane; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Down-Regulation; Endocytosis; Epithelial Cells; Humans; Ion Channel Gating; Mutation; Quinolones; Suppression, Genetic; Time Factors | 2014 |
Iron(III) chloride and diorganyl diselenides-mediated 6-endo-dig cyclization of arylpropiolates and arylpropiolamides leading to 3-organoselenyl-2H-coumarins and 3-organoselenyl-quinolinones.
Topics: Catalysis; Chlorides; Coumarins; Cyclization; Ferric Compounds; Molecular Structure; Propionates; Quinolones; Selenium Compounds; Stereoisomerism | 2014 |
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Biological Assay; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genotype; Humans; In Vitro Techniques; Mutation; Organoids; Quinolones | 2016 |
Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor.
Topics: Adolescent; Adult; Aminophenols; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Male; Membrane Potentials; Middle Aged; Mutation; Nasal Mucosa; Outcome Assessment, Health Care; Quinolones; Sweat; Treatment Outcome | 2017 |
Correlation of sweat chloride and percent predicted FEV
Topics: Aminophenols; Biomarkers; Chloride Channel Agonists; Chlorides; Clinical Trials as Topic; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Forced Expiratory Volume; Humans; Mutation; Predictive Value of Tests; Quinolones; Sweat; Treatment Outcome | 2017 |
Functional expression of G protein-coupled receptor 30 in immature rat epididymal epithelium.
Topics: Animals; Blotting, Western; Cells, Cultured; Chlorides; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Epididymis; Epithelial Cells; Gene Expression Regulation; Male; Microscopy, Fluorescence; Osmotic Pressure; Patch-Clamp Techniques; Quinolines; Quinolones; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; Sperm Motility | 2017 |
Effects of Ivacaftor in Three Pediatric Siblings With Cystic Fibrosis Carrying the Mutations G551D And F508del.
Topics: Adolescent; Aminophenols; Child, Preschool; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Genotype; Humans; Ion Transport; Male; Mutation, Missense; Pancreas; Quinolones; Sequence Deletion; Treatment Outcome | 2018 |
Ivacaftor-induced sweat chloride reductions correlate with increases in airway surface liquid pH in cystic fibrosis.
Topics: Adult; Aminophenols; Animals; Bicarbonates; Biological Transport, Active; Bronchoalveolar Lavage Fluid; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Female; Humans; Hydrogen-Ion Concentration; Infant; Infant, Newborn; Ion Transport; Longitudinal Studies; Lung; Male; Middle Aged; Mutation; Quinolones; Respiratory Mucosa; Sweat; Young Adult | 2018 |
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations.
Topics: Adolescent; Adult; Aminophenols; Child; Chloride Channel Agonists; Chlorides; Compassionate Use Trials; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Forced Expiratory Volume; Humans; Ion Channel Gating; Lung; Male; Middle Aged; Mutation; Quinolones; Respiratory Function Tests; Retrospective Studies; Sweat | 2019 |
Females with Cystic Fibrosis Demonstrate a Differential Response Profile to Ivacaftor Compared with Males.
Topics: Adolescent; Adult; Age Factors; Aminophenols; Body Mass Index; Body Weight; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Male; Quinolones; Sex Factors; Sweat; Young Adult | 2020 |
Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males.
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Body Mass Index; Child; Chlorides; Correlation of Data; Cystic Fibrosis; Drug Combinations; Female; Forced Expiratory Volume; Humans; Male; Quinolones; Retrospective Studies; Sex Factors; Sweat; Young Adult | 2021 |
Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.
Topics: Aminophenols; Bronchi; Cell Line, Tumor; Cells, Cultured; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Ion Transport; Mutation; Oligodeoxyribonucleotides, Antisense; Quinolones; RNA Splicing | 2020 |
Comparison of Organoid Swelling and
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Child; Chlorides; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Edema; Female; Forced Expiratory Volume; Homozygote; Humans; In Vitro Techniques; Male; Membrane Potentials; Middle Aged; Nasal Mucosa; Organoids; Precision Medicine; Prospective Studies; Quinolones; Rectum; Sweat; Treatment Outcome; Vital Capacity; Young Adult | 2020 |
Measuring the impact of CFTR modulation on sweat chloride in cystic fibrosis: Rationale and design of the CHEC-SC study.
Topics: Adolescent; Adult; Aged; Aminophenols; Aminopyridines; Benzodioxoles; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Female; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Sweat | 2021 |
Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations.
Topics: Aminophenols; Aminopyridines; Animals; Benzoates; Benzodioxoles; Benzopyrans; Cell Line; Chlorides; Codon, Nonsense; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Ion Transport; Protein Biosynthesis; Pyrans; Pyrazoles; Quinolones; Rats; Recovery of Function; Thyroid Epithelial Cells | 2021 |
Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Cells, Cultured; Child, Preschool; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Female; Genotype; Humans; Mutation, Missense; Nasal Mucosa; Pancreatic Elastase; Quinolones | 2021 |
CFTR modulation with elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis assessed by the β-adrenergic sweat rate assay.
Topics: Adrenergic Agents; Aminophenols; Benzodioxoles; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Indoles; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Sweat | 2022 |
Rescue of chloride and bicarbonate transport by elexacaftor-ivacaftor-tezacaftor in organoid-derived CF intestinal and cholangiocyte monolayers.
Topics: Aminophenols; Benzodioxoles; Bicarbonates; Chloride Channel Agonists; Chloride-Bicarbonate Antiporters; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Epithelial Cells; Humans; Indoles; Organoids; Pyrazoles; Pyridines; Pyrrolidines; Quinolones | 2022 |
Proximity Profiling of the CFTR Interaction Landscape in Response to Orkambi.
Topics: Adaptor Proteins, Signal Transducing; Aminophenols; Aminopyridines; Benzodioxoles; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; HEK293 Cells; Humans; Mass Spectrometry; Mutation; Protein Interaction Maps; Quinolones; Vesicular Transport Proteins | 2022 |
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis.
Topics: Adolescent; Adult; Aminophenols; Benzodioxoles; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Indoles; Middle Aged; Mutation; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Sinusitis; Young Adult | 2022 |
CFTR bearing variant p.Phe312del exhibits function inconsistent with phenotype and negligible response to ivacaftor.
Topics: Aminophenols; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Phenotype; Quinolones | 2022 |
EEM-PARAFAC as a convenient methodology to study fluorescent emerging pollutants degradation: (fluoro)quinolones oxidation in different water matrices.
Topics: Anti-Bacterial Agents; Chlorides; Ciprofloxacin; Coloring Agents; Enrofloxacin; Environmental Pollutants; Ferric Compounds; Humic Substances; Hydrogen Peroxide; Iron; Ofloxacin; Oxolinic Acid; Quinolones; Thiabendazole; Wastewater; Water; Water Pollutants, Chemical | 2022 |
Modulator Combination Improves In Vitro the Microrheological Properties of the Airway Surface Liquid of Cystic Fibrosis Airway Epithelia.
Topics: Aminophenols; Benzodioxoles; Bicarbonates; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mutation; Phenylalanine; Quinolones | 2022 |